Back
DFA Dimensional World ex US Core Equity 2 ETF Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison
Buy
62
DFAX
DFA Dimensional World ex US Core Equity 2 ETF
Last Price:
$32.17
Seasonality Move:
9.64%
Buy
57
DRUG
Bright Minds Biosciences, Inc.
Last Price:
$85.70
Seasonality Move:
-32.16%
Buy
62
DFA Dimensional World ex US Core Equity 2 ETF (DFAX)
is a Buy
Is DFA Dimensional World ex US Core Equity 2 ETF a Buy, Sell or Hold?
-
The current DFA Dimensional World ex US Core Equity 2 ETF [DFAX] share price is $31.92. The Score for DFAX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
DFAX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Bright Minds Biosciences, Inc. (DRUG)
is a Buy
Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?
-
The current Bright Minds Biosciences, Inc. [DRUG] share price is $88.08. The Score for DRUG is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
DRUG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DFAX Stock Price Chart
What is DFA Dimensional World ex US Core Equity 2 ETF's stock price today?
-
The DFA Dimensional World ex US Core Equity 2 ETF share price today is $31.92The current trend is moderately bearish and DFAX is experiencing selling pressure, which indicates risk of future bearish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences, Inc.'s stock price today?
-
The Bright Minds Biosciences, Inc. share price today is $88.08Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight selling pressure.
DFAX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 48.11 | Sell |
| Chaikin Money Flow: | -767565 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.5 - 32.4) | Sell |
| Bollinger Bands (100): | (30.52 - 32.04) | Buy |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.77 | Buy |
| Relative Strength Index (14 RSI): | 66.44 | Buy |
| Chaikin Money Flow: | -23974 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (59.51 - 82.89) | Buy |
| Bollinger Bands (100): | (41.26 - 68.88) | Buy |
DFAX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.3 | Sell |
| 20-day SMA: | 31.96 | Sell |
| 50-day SMA: | 31.79 | Buy |
| 200-day SMA: | 29.52 | Buy |
| 8-day EMA: | 32.21 | Sell |
| 20-day EMA: | 32.08 | Sell |
| 50-day EMA: | 31.78 | Buy |
| 200-day EMA: | 29.89 | Buy |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 85.48 | Buy |
| 20-day SMA: | 74.4 | Buy |
| 50-day SMA: | 65.57 | Buy |
| 200-day SMA: | 42.82 | Buy |
| 8-day EMA: | 85.2 | Buy |
| 20-day EMA: | 77.09 | Buy |
| 50-day EMA: | 66.93 | Buy |
| 200-day EMA: | 47.3 | Buy |
DFA Dimensional World ex US Core Equity 2 ETF Earnings Growth & DFAX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.
DFA Dimensional World ex US Core Equity 2 ETF Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||